Dr. Wierda on the Importance of Clinical Trials - CLL Support

CLL Support

22,987 members39,473 posts

Dr. Wierda on the Importance of Clinical Trials

bkoffman profile image
bkoffmanCLL CURE Hero
5 Replies

I’m home from the European Hematology Association Congress in Copenhagen.

I received very positive feedback on my lecture and the preliminary data from our Reader Poll with many requests for more information. We plan to follow up with another survey, Seems the 1000 plus hematologists to whom I presented the data and the folks from industry really want to know what we patients think and want.

I attended several lectures on CLL, reviewed dozens of abstracts, and had some great interviews with world experts that I look forward to sharing with you in the near future.

After the last long day, I finally got out of the convention center long enough to walk along the harbor and see the famous The Little Mermaid statue.

This week in the Clinical Trials/The Basics section of our website we’ve posted an interview with Dr. Bill Wierda of MDACC where we talked about the value of clinical trials and how he approaches the discussion with patients about joining a clinical trial. You can read a summary of our discussion and watch my interview with Dr. Wierda here. cllsociety.org/2016/06/dr-w...

In the meantime….

Stay strong.

We are all in this together.

Brian Koffman, MD

Volunteer Medical Director of the CLL Society

cllsociety.org

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
5 Replies
nvp815 profile image
nvp815

Great interview Brian. Thank you for all you do for us!!! You are a national (and international) treasure!!

Name-1 profile image
Name-1

Thank You,Brian!

Saidie profile image
Saidie

Do you know anything about BPDCN please.My dad has just been diagnosed.

Ladydi49 profile image
Ladydi49 in reply to Saidie

What do those letters stand for.....thanks

bkoffman profile image
bkoffmanCLL CURE Hero

Sorry to hear of his challenge. I have no expertise in BPDCN

Not what you're looking for?

You may also like...

ASH 2016: Dr. Mato on real world data on ibrutinib

Hi, This week I'm posting an interview that I had with Dr. Anthony Mato from U Penn when we talked...

Clinical Trials studying COVID-19 vaccines in CLL: Some have begun/ others are coming!

Clinical Trials studying COVID-19 vaccines in CLL: In response to all those who have reached out to...

ASH 2014. Dr. Sharman discusses the biology of our CLL cells

Friends, This week on the CLL Society website http://cllsociety.org, we share the first part of an...

ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL

We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...

Dr. Kanti Rai on the Future of CLL Therapy

Friends, This week we have posted an interview with one and only Dr. Kanti Rai when he sat down to...